Acinetobacter baumannii is found only rarely as part of the normal skin microflora, with one study estimating that only 3% at most of the population are colonized by the bacterium. This case report describes an outbreak of multidrug resistant acinetobacter baumannii in the intensive care unit of a tertiary care hospital. Acinetobacter fact sheet utah department of health. The diagnosis of acinetobacter infection is made by the growth of acinetobacter from a patient specimen eg, sputum, blood, cerebrospinal fluid in the setting of other clinical findings that suggest an infection at that site. Healthcare provider information sheet for acinetobacter. Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible for hospitalacquired nosocomial infections in the modern healthcare system. Structural insights into outer membrane permeability of. Heres what you need to know to prevent these infections. Acinetobacter baumannii is a gramnegative bacillus with an emerging multiresistance to antibiotics, making more and more difficult the treatment of hospitalacquired infections in which it is. Under the microscope, it looks halfway between a rod and a ball. As a consequence of its immense ability to acquire or upregulate antibiotic drug resistance determinants, it has justifiably been propelled to the forefront of scientific attention. Acinetobacter baumannii is a topic covered in the johns hopkins abx guide to view the entire topic, please sign in or purchase a subscription official website of the johns hopkins antibiotic abx, hiv, diabetes, and psychiatry guides, powered by unbound medicine.
Consulted experts internal experts consulted in alphabetical order. It can also colonize or live in a patient without causing infections or symptoms, especially in respiratory secretions sputum or open wounds. Acinetobacter baumannii remains an important and difficulttotreat pathogen whose. Carbapenemresistant acinetobacter baumannii in healthcare. Acinetobacter baumannii is an opportunistic bacterial pathogen primarily associated with hospitalacquired infections. While there are many types or species of acinetobacter and all can cause human disease, acinetobacter baumannii accounts for about 80% of reported infections. A pmrbregulated deacetylase required for lipid a modification and polymyxin resistance in acinetobacter baumannii. The challenge for the clinician is to combine local susceptibility patterns with the. Polymyxins are often lastline therapeutic agents used to treat infections caused by multidrugresistant a. The importance of guidelines in the development and application of probiotics. Acinetobacter baumannii is emerging infectious diseases resistant to several antibiotics early diagnosis and optimal treatment can reduce morbidity and mortali. To overcome this problem, knowledge of the pathogenesis. Acinetobacter baumannii infection aftercare instructions. Antimicrobial susceptibility of acinetobacter baumannii.
Acinetobacter baumannii can cause infections in the blood, urinary tract, and lungs pneumonia, or in wounds in other parts of the body. Acinetobacter baumannii, extensively drugresistant, tigecycline. Acinetobacter species belong to a group of gramnegative bacteria that are readily found throughout the environment including drinking and surface waters, soil, sewage and various types of foods. It can be an opportunistic pathogen in humans, affecting people with compromised immune systems, and is becoming increasingly important as a hospitalderived infection. Resistance to antimicrobials including colistin epidemiology of microorganism including survival of a. Acinetobacter baumannii is a opportunistic nosocomial pathogen, it has a high incidence among immunocompromised individuals, arising largely from its extensive antibiotic resistance spectrum. Acinetobacter baumannii is a typically short, almost round, rodshaped coccobacillus gramnegative bacterium. Management of multidrugresistant acinetobacter spp. A number of studies have reported promising results regarding the efficacy of sulbactam against a. Acinetobacter baumannii an overview sciencedirect topics. It can cause serious infections in the lungs, blood, and brain. Pdf current control and treatment of multidrugresistant.
Due to its ability to acquire resistance to commonly used antibiotics, more. Acinetobacter is a gramnegative coccobacillus figure 11,2 that during the past three decades has emerged from an organism of questionable pathogenicity to an infectious agent of importance to ho. Summary acinetobacter baumannii has emerged as a highly troublesome pathogen for many institutions globally. Acinetobacter species can acquire resistance genes from other. Evolution of antimicrobial resistancetreatment options yohei doi, md, phd1 gerald l. Healthcare provider information sheet for multidrugresistant acinetobacter baumannii mdrab division of infectious disease epidemiology dide 350 capitol street, room 125, charleston, wv 2530715 phone. Treatment of acinetobacter infections clinical infectious diseases. Due to the prevalence of infections and outbreaks caused by multidrug resistant a. An acinetobacter baumannii infection is caused by the acinetobacter baumannii bacteria germ. Notably, imipenem treatment of the imipenemresistant a. Acinetobacter bacteria can also be found on the skin of healthy people, especially healthcare personnel. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrugresistant mdr strains.
Acinetobacter baumannii specifically targets moist tissues such as mucous membranes or areas of the skin that are exposed, either through accident or injury. Acinetobacter baumannii is a bacterium in the acinetobacter genus which can be dangerous for human beings who have compromised immune systems, causing opportunistic infections which can lead to death if the patient does not receive aggressive treatment. Optimal therapy for multidrugresistant acinetobacter. Drugresistant acinetobacter healthcare setting fact sheet. The present study was focused on evaluate biofilm, pellicle formation, gelatinase activity, bacteriocin.
This germ may be found on skin or in food, water, or soil. Acinetobacter baumannii has emerged in the last decades as a major cause of healthcareassociated infections. Since acinetobacter colonization is common and treatment difficult and potentially associated with substantial toxicity, the distinction between colonization and. The population structure of acb has been studied using two 7gene mlst schemes, introduced by bartual and coworkers oxford scheme and by diancourt and coworkers pasteur scheme. The drugresistant nature of the pathogen and its unusual and unpredictable susceptibility patterns make empirical and therapeutic decisions even more difficult. Its ability to survive in a hospital milieu and its ability to persist for extended periods of time on surfaces makes it a frequent cause for healthcareassociated infections and it has led to multiple outbreaks. Acinetobacter baumannii can cause serious infections in the lungs, blood, and brain. The acinetobacter superbug can cause diseases such as pneumonia and meningitis. Research multidrugresistant acinetobacter baumannii. Antimicrobial susceptibility of acinetobacter baumannii isolated from hospital patients wanutsanun tunyapanit a. Because of complex epidemiology, infection control of these outbreaks is difficult to attain. Acinetobacter baumannii lab diagnosis, treatment and.
Three patients were infected on the same day from an. An acinetobacter baumannii infection is caused by the acinetobacter baumannii bacteria. Antimicrobial agents for the treatment of acinetobacter infections. Institutional outbreaks caused by acinetobacter baumannii strains that have acquired multiple mechanisms of antimicrobial drug resistance constitute a growing publichealth problem. Multidrugresistant acinetobacter baumannii is recognized to be. Acinetobacter baumannii, a nonfermenter gramnegative coccobacillus, was considered a lowcategory pathogen in the past, but has now emerged as a leading cause of hospital and communityacquired infections. Peleg,mbbs,phd,mph,fracp2,3 1division of infectious diseases, department of medicine, university of pittsburgh school of medicine, pittsburgh, pennsylvania. Successful treatment of extensively drugresistant acinetobacter. The recent increase in incidence, largely associated with infected combat troops returning from conflict zones, coupled with a dramatic increase in the incidence of multidrugresistant mdr strains, has significantly raised the profile of this emerging opportunistic pathogen. Acinetobacter baumannii is a pleomorphic aerobic gramnegative bacillus similar in appearance to haemophilus influenzae on gram stain commonly isolated from the hospital environment and hospitalized patients. Acinetobacter baumannii is one of the escape organisms, a group of. Matching of orthologous genes, defined as gene pairs with a pvalue of merge data from the present study with a previously published transcriptomic dataset from a. The circumstances of some outbreaks demonstrated the long survival of acinetobacter in a dry, inanimate environment. Current control and treatment of multidrugresistant.
Acinetobacter baumannii is a bacterium that can cause a range of diseases. It may also cause urinary tract and wound infections. Acinetobacter baumannii is a gramnegative coccobacillus that has been listed as the most important pathogen in hospitals 1. Apart from its predilection for the seriously ill within intensive care units, a. Treatment acinetobacter is often resistant to many commonly prescribed antibiotics.
Effective antibiotic treatment of a baumannii infections, such as. Acinetobacter baumannii remains an important and difficulttotreat pathogen whose resistance patterns result in significant challenges for the clinician. Comparative analysis of the two acinetobacter baumannii. It is a frequent cause of pneumonia and septicemia in immunocompromised patients. Acinetobacter baumannii is an important causative agent of nosocomial infections, and carbapenems have been frequently used in the treatment of these. Antibiotic resistance in the gramnegative bacterium acinetobacter baumannii is caused in part by a lowpermeability outer membrane om. Acinetobacter species assigned to the acinetobacter calcoaceticusbaumannii acb complex, are gramnegative bacteria responsible for a large number of human infections. In acinetobacter baumannii is immobile, aerobic, gramnegative short rods with a size of about 11. In recent news, an antibioticresistant strain of a. Habitat and morphology of acinetobacter baumannii online. Drug treatment for multidrugresistant acinetobacter. Practice guidelines for the management of bacterial meningitis. Acinetobacter baumannii has proven to be an increasingly important and demanding species in health careassociated infections. Pdf institutional outbreaks caused by acinetobacter baumannii strains that have.
1558 586 773 153 957 1082 166 917 825 1109 1566 341 1646 1241 933 544 1652 811 1358 659 1496 560 451 974 636 925 602 227 203 501 1392 679 78 160 711 1310